Provided by Tiger Trade Technology Pte. Ltd.

Cellebrite

17.81
+0.67003.91%
Post-market: 18.130.3200+1.80%17:42 EST
Volume:1.63M
Turnover:28.94M
Market Cap:4.35B
PE:56.90
High:18.07
Open:17.24
Low:17.24
Close:17.14
52wk High:26.30
52wk Low:13.10
Shares:244.00M
Float Shares:112.43M
Volume Ratio:1.77
T/O Rate:1.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3130
EPS(LYR):-1.3510
ROE:20.46%
ROA:5.24%
PB:9.71
PE(LYR):-13.18

Loading ...

BRIEF-Cellebrite Completes Acquisition Of Corellium

Reuters
·
Yesterday

BRIEF-Cellebrite Di Ltd Not Updating Its Q4 And Full-Year 2025 Outlook At This Time

Reuters
·
Yesterday

Cellebrite DI Ltd: Guidance Not Updated as Q4 Impact From One Month of Corellium's Revenue & Costs Is Not Expected to Be Material

THOMSON REUTERS
·
Yesterday

Cellebrite DI Ltd: Not Updating Its Q4 and Full-Year 2025 Outlook at This Time

THOMSON REUTERS
·
Yesterday

Cellebrite Closes Acquisition of Corellium

Reuters
·
Yesterday

Press Release: Cellebrite Completes Acquisition of Corellium, Extending the Industry's Most Advanced AI-Powered Digital Investigation Platform

Dow Jones
·
Yesterday

High Growth Tech Stocks In The US For November 2025

Simply Wall St.
·
Nov 24

Cellebrite (NasdaqGS:CLBT): Assessing Valuation After Strong Updated Earnings Guidance and Growth Outlook

Simply Wall St.
·
Nov 19

These Fast-Rising Tech Stocks Are Surging in Growth Scores This Week

Benzinga_recent_news
·
Nov 18

Cellebrite DI Ltd. Publishes Transcript of Q3 2025 Financial Results Conference Call

Reuters
·
Nov 17

Is Cellebrite DI’s Latest Law Enforcement Partnerships Enough to Support Its Current Stock Valuation?

Simply Wall St.
·
Nov 16

BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APA

Reuters
·
Nov 14

Cellebrite rises 24.4%

TIPRANKS
·
Nov 13

Stock Track | Cellebrite Soars 21.35% on Strong Q3 Results, Raised Guidance, and Analyst Upgrades

Stock Track
·
Nov 13

Deutsche Bank Raises Price Target on Cellebrite to $24 From $21, Keeps Buy Rating

MT Newswires Live
·
Nov 13

Cellebrite price target raised to $25 from $24 at BofA

TIPRANKS
·
Nov 13

Cellebrite DI (CLBT) Gets a Buy from J.P. Morgan

TIPRANKS
·
Nov 13

Cellebrite DI: Strong Financial Performance and Promising Growth Prospects Drive Buy Rating

TIPRANKS
·
Nov 13

Cellebrite DI Is Maintained at Buy by Needham

Dow Jones
·
Nov 13

Cellebrite DI Positioned for Growth: Buy Rating Affirmed Amid Federal Demand Recovery and Strategic Alignments

TIPRANKS
·
Nov 13